| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.30▼ | 2.31▼ | 2.31▼ | 2.33▼ | 3.31▼ |
| MA10 | 2.30▼ | 2.26▲ | 2.28▲ | 2.51▼ | 3.21▼ |
| MA20 | 2.31▼ | 2.33▼ | 2.36▼ | 3.01▼ | 3.46▼ |
| MA50 | 2.47▼ | 2.60▼ | 2.69▼ | 3.13▼ | 3.86▼ |
| MA100 | 2.74▼ | 3.32▼ | 3.31▼ | 3.38▼ | 3.95▼ |
| MA200 | 3.44▼ | 3.78▼ | 3.88▼ | 3.68▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.014▲ | 0.021▲ | 0.027▲ | -0.109▼ | -0.082▼ |
| RSI | 44.620▼ | 42.857▼ | 40.243▼ | 42.652▼ | 41.948▼ |
| STOCH | 55.302 | 62.469 | 58.161 | 6.978▼ | 20.737 |
| WILL %R | -36.538 | -36.538 | -59.756 | -97.532▼ | -97.532▼ |
| CCI | 33.158 | 26.788 | -15.067 | -72.836 | -129.791▼ |
|
Monday, October 27, 2025 02:31 PM
Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next. Click for my GNTA update.
|
|
Monday, October 27, 2025 09:11 AM
Genenta Science SpA (NASDAQ:GNTA) shares sank 42% on Monday after the clinical-stage biotech company unveiled a new stock offering that will significantly dilute existing shareholders. The firm said ...
|
|
Monday, October 27, 2025 07:07 AM
The clinical-stage biotechnology firm revealed it has entered into a securities purchase agreement with institutional investors to sell 4,285,715 American Depositary Shares at $3.50 per ADS. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 2.30 | 2.31 | 2.27 | 2.295 | 50,131 |
| 07/11/25 | 2.47 | 2.47 | 2.10 | 2.30 | 217,323 |
| 06/11/25 | 2.55 | 2.55 | 2.21 | 2.29 | 247,004 |
| 05/11/25 | 2.33 | 2.56 | 2.3102 | 2.46 | 135,586 |
| 04/11/25 | 2.61 | 2.62 | 2.30 | 2.30 | 269,895 |
| 03/11/25 | 2.61 | 2.75 | 2.55 | 2.56 | 238,791 |
| 31/10/25 | 2.88 | 2.93 | 2.54 | 2.57 | 296,199 |
| 30/10/25 | 3.02 | 3.15 | 2.85 | 2.87 | 671,162 |
| 29/10/25 | 2.76 | 3.2494 | 2.71 | 3.01 | 12,973,100 |
| 28/10/25 | 3.39 | 3.39 | 2.33 | 2.40 | 814,643 |
|
|
||||
|
|
||||
|
|